All Immunology articles – Page 18
-
NewsResearchers identify ‘neuroimmune signature’ that can predict viral hepatitis complications
A network of genes linked to the nervous and immune systems can predict cancer risk and even explain symptoms such as fatigue and depression resulting from viral hepatitis infection.
-
NewsScientists develop shape-shifting scaffold that fights infection and rebuilds bone
Scientists have developed a body-temperature–responsive, 3D-printed shape-memory scaffold coated with a metal–polyphenol network to treat infectious bone defects. It is designed to adapt to irregular bone defects while providing antibacterial activity, immune regulation, and osteogenic support.
-
NewsBacteria found in mouth and gut may help protect against severe peanut allergic reactions
One of the big mysteries in food allergy is why two people with similar levels of peanut specific antibodies can react so differently. A new study shows for the first time how gut bacteria break down parts of an allergenic food and influence how a person reacts to peanuts.
-
NewsStudy finds natural fungal supplement improves COVID-19 vaccine response
Researchers have found that a natural fungal supplement taken at the time of COVID-19 vaccination reduced short-term vaccine side effects and helped antibodies last longer in people who had not previously been exposed to the virus.
-
NewsEditing for timing, not overdrive: A new genetic route to fire blight resistance in apple
Fire blight remains one of the most destructive bacterial diseases threatening global apple production. A new study identifies a family of inducible lectin genes, MdAGGs, as critical components of apple immune defense and demonstrates that their precise activation timing is key to effective resistance.
-
NewsNanoparticle vaccine approach takes on a new target: Hepatitis C virus
Scientists have engineered a native-like, stabilized version of Hepatitis C virus’s E1E2 complex and used it to build a nanoparticle-based vaccine candidate. It uses a technology called self-assembling protein nanoparticles, which organizes copies of the proteins into virus-like clusters that the immune system can recognize.
-
NewsScientists identify therapeutic target that would curb the spread of coronaviruses
Coronaviruses not only use the machinery of the human cells they infect: they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly, according to a study identifying enzymes that modify transfer RNAs as key elements for coronavirus infection.
-
NewsEpigenetic rewiring fuels potato susceptibility to late blight
Scientists performed whole-genome bisulfite sequencing and RNA sequencing on the widely cultivated potato cultivar Qingshu No.9 following Phytophthora infestans infection, uncovering dynamic DNA methylation shifts that correlate with large-scale transcriptional reprogramming and immune suppression.
-
NewsStudy reveals immune blueprint for next-generation malaria vaccine
New research has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of malaria. It provides critical evidence of how protective immunity to P. vivax works, identifying specific targets on the parasite.
-
NewsProtein interplay offers insights into how the immune system recognizes viral RNA
A new study reveals how two proteins cooperate in a key early step of antiviral detection. Using cryo-electron microscopy and high-speed atomic force microscopy, researchers found that LGP2 binds to viral RNA and recruits MDA5 molecules, as if threading beads on a string.
-
NewsPeople’s gut bacteria worse in areas with higher social deprivation
Living in a poorer neighbourhood in the UK could impact the make-up of your gut microbiome, potentially leading to worse health. New research found that people living in areas of higher social deprivation have a less diverse range of bacteria in their gut.
-
NewsDiffering immune responses in infants may explain increased severity of RSV over SARS-CoV-2
Reseachers report that the two respiratory viruses trigger different immune responses. Those differences might explain why these two diseases have different clinical outcomes and require different treatment strategies.
-
NewsMeningococcal B vaccination does not reduce gonorrhoea, trial results show
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhoea, according to the results of the world’s largest randomised control trial (RCT) into possible efficacy.
-
NewsHow citrus rewires its vascular system to fight Huanglongbing
By profiling thousands of individual cells, researchers mapped how different vascular cell types in citrus roots respond during early stages of infection with Candidatus Liberibacter asiaticus, revealing profound changes in cell fate, gene expression, and tissue differentiation.
-
NewsStudy reveals key differences in long-term brain effects of COVID-19 and flu
While both Covid and flu can leave lasting lung damage, only SARS-CoV-2 infection caused persistent brain inflammation and small blood vessel injury, even after the virus was no longer detectable, a new study has found.
-
NewsNew strategies aim at HIV’s last strongholds
A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.
-
News Huayunuo approval positions China at forefront of viral hepatitis innovation, says GlobalData
Huahui Health has recently secured conditional approval from China for Huayunuo (Libevitug Injection), marking it as the first domestically developed monoclonal antibody (mAb) drug for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis.
-
NewsNovel camel antimicrobial peptides show promise against drug-resistant bacteria
Researchers have identified three novel antimicrobial peptides (AMPs) from dromedary camels that effectively target multidrug-resistant bacteria, offering potential alternatives to conventional drugs.
-
NewsNew single-cell transcriptomic clock reveals intrinsic and systemic T cell aging in COVID-19 and HIV
Scientists developed a new single-cell transcriptomic clock called T immune cell transcriptomic clock (Tictock) to measure aging in specific immune cells. They found that in patients with acute Covid-19, the infection increased the biological age of naïve CD8 T cells.
-
NewsHoly Grail: One vaccine may provide broad protection against many respiratory infections and allergens
In a new study in mice, researchers have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens.